Point-of-Care Diagnostics Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025 - Market Research Engine The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Point-of-Care Diagnostics market share. Major industry players with significant revenue share include Becton Dickinson, Johnson & Johnson, Nipro, Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Abaxis, Samsung Medison, Bayer, Danaher Corporation, and others. Point-of-Care Diagnostics Market is expected to exceed more than US$ 45.6 Billion by 2024 at a CAGR of 9.6% in the given forecast period. Browse Full Report: https://www.marketresearchengine.com/point-of-carediagnostics-market The global Point-of-Care Diagnostics market is segregated on the basis of Product as Urinalysis Testing Kits, Cholesterol Test Strips, Drugs-Of-Abuse Testing Kits, Tumor/Cancer Markers, Glucose Monitoring Kits, Infectious Diseases Testing Kits, Cardiometabolic Monitoring Kits, Coagulation Monitoring Kits, Hematology Testing Kits, and Other. Based on End-User the global Point-of-Care Diagnostics market is segmented in Hospitals, Ambulatory Care, and Home. The global Point-of-Care Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Point-ofCare Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others. Factors, for example, high predominance of irresistible diseases in developing nations, rising rate of target diseases, and growing inclination for home healthcare over the globe are growing the selection of POC diagnostics items universally. Rising speculation by numerous open associations is even a driving element for the growth of POC diagnostic market. Point-of-care (POC) diagnostics or near-patient testing is a medicinal analytic test that enables doctors and restorative staff to accurately accomplish constant, lab-quality diagnostic outcomes inside minutes instead of hours. Using versatile blood analyzers, testing at the "purpose of consideration" streamlines the diagnostic procedure and guarantees patients get the best and proficient consideration when and where it is required. Point-of-care (POC) diagnostic testing grants staff to settle on fast triage and treatment choices when diagnosing a patient's condition or checking a treatment reaction. Competitive Rivalry Becton Dickinson, Johnson & Johnson, Nipro, Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Abaxis, Samsung Medison, Bayer, Danaher Corporation, and others are among the major players in the global Point-of-Care Diagnostics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain. The Point-of-Care Diagnostics Market has been segmented as below:
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.